Crash and burn: The four biggest biopharma failures of 2019 – STAT

Published in BMJ Open Sport and Exercise, the study looked at athletes with spinal cord injuries to better understand neuropathic pain.

The overlapping symptoms of long Covid and persistent Lyme challenge patients and doctors alike. Researchers are seeking biomarkers and devising “cross-illness” trials.

Blood tests set to norms based on the physiology of white men can lead to misdiagnosis and unnecessary health scares for people of different races.

Pediatric cancer treatments have been neglected. Two U.K. charities are starting a consortium to advance new molecules to a “drug candidate” stage, for handoff to…

Could raw milk — or a cat — help explain how a person who had no contact with animals caught H5 bird flu?

The insurer UnitedHealth is using its unrivaled physician empire to enrich itself by milking Medicare Advantage.

In a first, a new heart disease risk calculator uses social factors to try to make predictions more accurate.

A CRISPR-augmented stem cell transplant has shown preliminary evidence that it can delay relapse in some cancer patients. 

In a historic first, detailed data show a therapy developed by Summit Therapeutics beat Merck blockbuster Keytruda in late-stage lung cancer trial.

Kidney specialists now acknowledge millions of Black patients may have been undertreated and even denied transplants because of a race-adjusted test.